Dose concomitant HIV infection has any epidemiological, clinical, immunopathological and therapeutic relevance in leprosy?

Indian Journal of Leprosy

Volumn 79, Issue 1, 2007, Pages 45-60

  Kar, H K ^a   Sharma, P ^a  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; CORTICOSTEROID; PENTOXIFYLLINE; STEROID;

DISEASE SEVERITY; DRUG MEGADOSE; DRUG MONITORING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; INDIA; LEPROSY; LONG TERM CARE; LOW DRUG DOSE; MALE; MASS SPECTROMETRY; NEURITIS; PATIENT MONITORING; PREVALENCE; RECURRENCE RISK; REVIEW; SUPERINFECTION; TREATMENT DURATION; TREATMENT RESPONSE; ADULT; ANIMAL; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; ANIMALS; FEMALE; HIV INFECTIONS; HUMANS; LEPROSY; MALE; MIDDLE AGED;

EID: 34249907558     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Andrade VL, Moreira Alves T, et al (1991). Prevalence of HIV-1 in leprosy patients in Rio de Jeneiro, Brazil. Int Lepr Other Mycobact Dis 59: 221-8
2. Borgdorff MW, Van den Broek J, Chum HJ, et al (1993). HIV-1 infection as a risk factor for leprosy; a case-control study in Tanzania. Int J Lepr Other Mycobact Dis 61: 556-62
3. Chatterjee M, Jaiswal AK (2002). Does pentoxifylline find a place in the armamentarium of leprologists in type II reaction? Indian J Lepr 74: 329-34
4. Cho SN, Cellona RV, Villaharnosa LG, et al (2001). Detection of phenolic glycolipid I OF Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin Diagn Lab Immunol 8: 138-42
5. Couppie P, Abel S, Voinchet H, et al (2004). Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol. 140: 997-1000
6. Gormus BJ, Murphey-Corb M, Martin LN, et al (1998). Impaired responses to Mycobacterium leprae antigens in rhesus monkeys experimentally inoculated with simian immunodeficiency virus and M leprae. Lepr Rev 69: 24-39
7. Gebre S, Saunderson P, Messile T, et al (2000). The effect of HIV status on the clinical picture of leprosy: a prospective study in Ethiopia. Lepr Rev 71: 338-43
8. Hussain T, Sinha S, Kulshreshtha KK, et al (2005). Seroprevalence of HIV infection among leprosy patients in Agra, India: trends and perspective. Int J Lepr Other Mycobact Dis 73: 93-9
9. Inamdar AC, Palit A, et al (2003). Generalized anetoderma in a patient with HIV and dual mycobacterial Infection. Lepr Rev 74: 275-8
10. Jacob M, George S, Pulimood S, et al (1996). Short-term follow up of patients with multibacillary leprosy and HIV infection. Int J Lepr Other Mycobact Dis 64: 392-5
11. Kawuma HJ, Bwire R, Adatu-Engwau F (1994). Leprosy and infection with the human immunodeficiency virus in Uganda: a case-control study. Int J Lepr Other Mycobact Dis 62: 521-6
12. Lawn SD, Wood C, Lockwood DN (2003). Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 36: e5-6
13. Leonard G, Sangare A, Verdier M, et al (1990). Prevalence of HIV infection among patients with leprosy in African countries and Yemen. J Acquir Immune Defic Syndr 3: 1109-13
14. Lienhardt C, Kamate B, Jamet P, et al (1996). Effect of HIV infection on leprosy: a three-year study in Bamako, Mali. Int J Lepr Other Mycobact Dis 64: 383-91
15. Lucas S (1993). Human immunodeficiency virus and leprosy. Lepr Rev 64: 97-103
16. Moses AE, Adelowo KA, Nwankwo EA (2001). Effect of HTV infection on the clinical spectrum of leprosy in Maiduguri. Niger Postgrad Med J 8: 74-7
17. Narang T, Dogra S, Kaur I (2005). Borderline tuberculoid leprosy with Type 1 reaction in an HIV patient - a phenomenon of immune reconstitution (Case report). Int J Lepr Other Mycobact Dis 73: 203-5
18. Orege PA, Fine PE, Lucas SB, et al (1993). A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in western Kenya. Tuber Lung Dis 74: 377-81
19. Pereira GA, Stefani MM, Araujo Filho JA, et al (2004). Human immuno-deficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am J Trap Med Hyg 71: 679-84
20. Ponnighaus JM, Mwanjasi, Fine PEM, et al (1991). Is HIV infection a risk factor for leprosy: Int J Lepr Other Mycobact Dis 59: 221-8
21. Rath N, Kar HK (2003). Leprosy in HIV infection: A study of three cases (Case report). Indian J Lepr 75: 355-9
22. Ravot E, Lisziewicz J, Lori F (1999). New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide. Drugs 58: 953-63
23. Roche PW, Britton WJ, Failbus SS, et al (1990). Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Int J Lepr Other Mycobact Dis 58: 480-90
24. Sampaio EP, Caneshi JR, Nery JA, et al (1995). Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect Immun 63: 1848-54
25. Sekhar B, Jayasheela M, Chattopadhyay D, et al (1994). Prevalence of HIV infection and high-risk characteristics among leprosy patients of south India: a case-control study. Int J Lepr Other Mycobact Dis 62: 527-31
26. Sharma NL, Mahajan VK, Sharma VC, et al (2005). Erythema nodosum leprosum and HIV infection: a therapeutic experience. Int J Lepr Other Mycobacterial Dis 73: 189-93
27. Singh TN, Nandakishore T, Singh L (2000). Leprosy with HIV infection in Manipur. Indian J Dermatol Venereol Leprol 66: 39-40
28. Singhal A, Mehta S, Pandhi D (2006). Immune reconstitution inflammatory syndrome in a HIV seropositive leprosy patient. Lepr Rev 77: 76-80
29. Trindade MA, Manini MA, Masetti JH, et al (2005). Leprosy and HIV co-infection in five patients. Lepr Rev 76: 162-6
30. Trindade MA, Valente NY, Manini MI, et al (2006). Two patients co-infected with Mycobacterium leprae and human immunodeficiency virus type-1 and naïve for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. J Clin Microbiol 44: 4616-8
31. Ustianowski AP, Lawn SD, Lockwood DN (2006). Interactions between HIV infection and leprosy: Lancet Infect Dis. 6: 350-60
32. van den Broek J, Chum HJ, Swai R, et al (1997). Association between leprosy and HIV infection in Tanzania. Int J Lepr Other Mycobact Dis 65: 203-10